Meng Xiangyin,Yu Lang,Li Wenbo,et al.Quality assurance test cases for stereotactic radiation therapy planning of multiple intracranial metastases[J].Chinese Journal of Radiological Medicine and Protection,2025,45(1):31-36 |
Quality assurance test cases for stereotactic radiation therapy planning of multiple intracranial metastases |
Received:May 09, 2024 |
DOI:10.3760/cma.j.cn112271-20240509-00169 |
KeyWords:Multiple intracranial metastases Stereotactic radiotherapy Test case |
FundProject:国家重点研发计划项目(2022YFC2404606);中央高水平医院临床科研业务费资助项目(2022-PUMCH-B-116) |
Author Name | Affiliation | E-mail | Meng Xiangyin | Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China | | Yu Lang | Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China | | Li Wenbo | Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China | | Wang Zhiqun | Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China | | Lian Xin | Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China | | Wang Jiaxin | Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China | | Sun Xiansong | Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China | | Leng Lingxuan | Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China | | Yang Bo | Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China | yb1632@163.com | Qiu Jie | Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China | |
|
Hits: 1574 |
Download times: 738 |
Abstract:: |
Objective To present a set of clinically representative quality assurance (QA) test cases for stereotactic radiosurgery (SRT) plans of multiple intracranial metastases, in order to assess the plan quality and machine execution capabilities. Methods Based on the clinical characteristics of multiple brain metastases, four groups of test cases with three target volumes (TVs), six TVs, nine TVs, and TVs near organs at risk (OARs) were designed. For these cases, SRT plans were developed, and plan quality was assessed using metrics including the Radiation Therapy Oncology Group conformality index (RTOG CI), gradient index (GI), homogeneity index (HI), and the volume of normal brain tissue receiving a dose of 24 Gy (V24 Gy), which was defined as the volume enclosed by the 24 Gy isodose line around the Brain-PTV (V24 Gy of Brain-PTV). Verification plans were generated for each test case, including the verification of point doses, planar doses (PD), and SRS MapCHECK (SMC) semiconductor matrix planar doses. Compared with the calculated result of the treatment planning system (TPS), the criteria for the γ analysis of planar doses were set at 1 mm/2% and 2 mm/2%. Results For the four groups of test cases, the mean CI, GI, HI, and V24 Gy of Brain-PTV were 1.04±0.03, 3.79±0.40, 0.73±0.01 and (7.46±3.80) cm3, respectively. The mean deviations of the point doses were 0.88%±0.98%, 1.47%±0.79%, 1.52%±0.76%, and 1.17% ±0.38%, respectively. The mean γ passing rates of the single fields for PDs were greater than 98% at 2 mm/2% and exceeding 96% at 1 mm/2%, and the mean γ pass rates of the SMC semiconductor matrix for PDs were 97.75% ±2.31% and 99.33% ±0.62%, at 1 mm/2% and 2 mm/2% respectively. Conclusions The proposed QA test cases for SRT of multiple intracranial metastases allow for the effective assessments of the plan quality and machine execution capabilities and, thus, can assist various centers in clinical applications. |
HTML View Full Text View/Add Comment Download reader |
Close |
|
|
|